Showing results (221-230 of 438) with videos related to

Sort By:
Pageof 44
European Journal of Cancer (Oxford, England : 1990)|October 25, 2025
Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trialEleonora Cristarella, Margherita Ambrosini, Massimo Di Maio, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2020
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord OvestRoberto Moretto, Daniele Rossini, Gemma Zucchelli, et al.
The Oncologist|April 14, 2026
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Margherita Ambrosini, Julien Taieb, et al.
Histopathology|May 29, 2026
Unveiling the molecular profile of adenosquamous gallbladder carcinoma: characterization of a Caucasian cohortJessica Gasparello, Valentina Angerilli, Mario Domenico Rizzato, et al.
The Oncologist|October 9, 2015
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New HopeFilippo Pietrantonio, Chiara Cremolini, Giuseppe Aprile, et al.
The Oncologist|December 18, 2020
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based AnalysisFilippo Pietrantonio, Giovanni Fucà, Daniele Rossini, et al.
BMC Cancer|June 11, 2017
TRIBE-2: a phase III, randomized, open-label, strategy trial in unresectable metastatic colorectal cancer patients by the GONO groupChiara Cremolini, Federica Marmorino, Fotios Loupakis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2023
Negative Hyperselection of Patients with HER2+ and RAS Wild-Type Metastatic Colorectal Cancer Receiving Dual HER2 Blockade: the PRESSING-HER2 StudyGiovanni Randon, Yoshiaki Nakamura, Rona Yaeger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Comparative Genomic Analysis and Clinical Outcomes of BRAF-mutated Advanced Biliary Tract CancersTin-Yun Tang, Federico Nichetti, Ben Kaplan, et al.
Nature|December 16, 2021
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancerYelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, et al.
Pageof 44